NCT07148765
Use of Wearables Following Cystectomy- Part II
Enrolling by Invitation
NAAges 18+InterventionalSupportive careUniversity of PittsburghInvestigator-initiated
~50 participants
Updated 2025-09-26 on ClinicalTrials.gov
What's tested:Fitbit Sense 2Smartphone application survey
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of participants who remain in the study from enrollment until trial completion (participant retention)
Measured over From enrollment to 30 days post-discharge following cystectomy hospitalization
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Matthew R Epstein, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
English-speaking
Owns a smartphone
Scheduled to undergo cystectomy with urinary diversion at a UPMC hospital
Exclusion
No reliable internet access
Concurrent enrollment in another interventional study that may interfere with outcomes
What this trial measures
- Proportion of participants who remain in the study from enrollment until trial completion (participant retention)From enrollment to 30 days post-discharge following cystectomy hospitalization
- Participant wearable electronic device adherenceFrom day of discharge following cystectomy hospitalization to 30 days post-discharge
Proportion of patients who wear and transmit data from the provided Fitbit Sense 2 device for at least 16 hours per day for more 14 days